Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use

Polycystic liver disease (PLD) is a common extrarenal complication of autosomal dominant polycystic kidney disease (ADPKD), which causes compression-related syndrome and ultimately leads to liver dysfunction. Tolvaptan, a V2 receptor antagonist, is widely used to protect kidney function in ADPKD but...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Hiroki, Sekine, Akinari, Suwabe, Tatsuya, Ikuma, Daisuke, Yamanouchi, Masayuki, Hasegawa, Eiko, Sawa, Naoki, Ubara, Yoshifumi, Hoshino, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853523/
https://www.ncbi.nlm.nih.gov/pubmed/35176098
http://dx.doi.org/10.1371/journal.pone.0264065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853523/
https://www.ncbi.nlm.nih.gov/pubmed/35176098
http://dx.doi.org/10.1371/journal.pone.0264065

Ejemplares similares